Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

Competition opens up the multi billion dollar gene expression analysis market

Kalorama Information : 15 January, 2008  (New Product)
A new market study released by Kalorama Information shows that new products and applications have made gene expression analysis a more competitive market in the past few years, which will lead to a market worth nearly $2.5 billion by 2012.
Real-time PCR, improvements in microarrays, and the increasing reality of clinical application beyond the research bench will propel double-digit growth in this segment for the next 5 years, according to the study.

The new study, Gene Expression Profiling Markets, found that gene expression analysis has progressed significantly in the past two years with the emergence of a number of new techniques and technologies impacting the market, including next-generation sequencers, SNP analysis, copy number variation, methylation analysis, alternative splicing analysis, ChIP-on-chip, and micro RNA technology. In addition, better standardisation and compatibility among technologies and increasing clarity regarding regulatory issues are fuelling healthy competition.

“The perception that the Affymetrix platform is the only reliable, reproducible platform available is changing,” noted Justin Saeks, analyst for Kalorama Information and the author of the study. “Customers thought they would never be able to compare legacy data with new data from other platforms; however, it has now been demonstrated that these fears are not justified, which has opened up the market to a host of new product introductions.”

Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo